Document Detail


Utility of the stroke-thrombolytic predictive instrument.
MedLine Citation:
PMID:  18420726     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: The goal of this study was to evaluate the utility of the stroke thrombolytic predictive instrument (s-TPI) in predicting clinical outcome in patients with acute ischaemic stroke treated with intravenous tissue plasminogen activator (t-PA). METHODS: The study assessed the external validity of the s-TPI in 301 consecutive stroke patients treated with intravenous t-PA. Clinical outcome was measured with the modified Rankin scale (mRs) at 3 months. The study used the s-TPI to calculate probabilities of a good outcome (mRs 0-1) and a poor outcome (mRs 5-6). We compared these probabilities with the observed outcome using receiver-operator characteristics (ROC) curves and calibration curves. Subgroup analyses for different onset-to-treatment time windows were performed. RESULTS: According to the s-TPI, the mean predicted probability of a good and a poor outcome in the validation cohort were 0.45 and 0.17. The area under the ROC curves were 0.80 (4.5-hour time window), 0.82 (3-hour time window) and 0.77 (3-4.5 hours time window) for predicting good outcome, and 0.78 (4.5 hours), 0.80 (3 hours) and 0.74 (3-4.5 hours) for predicting poor outcome. Calibration curves revealed a slight overestimation of probabilities of a good outcome and underestimation of probabilities of a poor outcome. CONCLUSIONS: The s-TPI appears to be reasonably valid for predicting outcome after t-PA treatment in daily practice, although a slight overestimation of a good and underestimation of a poor outcome was observed.
Authors:
M Uyttenboogaart; R E Stewart; P C Vroomen; G-J Luijckx; J De Keyser
Related Documents :
6842216 - Prognostic indicators and the pattern of recovery of communication in aphasic stroke pa...
20520216 - Potential role of group clinics to boost outcomes among elderly spanish-only speaking s...
23494156 - Pochonia chlamydosporia in the biological control of fasciola hepatica in cattle in sou...
12841556 - Perioperative stroke in coronary artery bypass patients.
23970206 - Evaluation of four tenofovir-containing regimens as first-line treatmentsin cameroon an...
23167296 - Safety of no bowel preparation before ileal urinary diversion.
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't     Date:  2008-04-17
Journal Detail:
Title:  Journal of neurology, neurosurgery, and psychiatry     Volume:  79     ISSN:  1468-330X     ISO Abbreviation:  J. Neurol. Neurosurg. Psychiatr.     Publication Date:  2008 Sep 
Date Detail:
Created Date:  2008-08-18     Completed Date:  2008-09-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  2985191R     Medline TA:  J Neurol Neurosurg Psychiatry     Country:  England    
Other Details:
Languages:  eng     Pagination:  1079-81     Citation Subset:  IM    
Affiliation:
Department of Neurology, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands. m.uyttenboogaart@neuro.umcg.nl
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Aged
Brain / blood supply*
Brain Ischemia / diagnosis*,  drug therapy*
Cerebrovascular Circulation / physiology
Female
Fibrinolytic Agents / therapeutic use*
Humans
Injections, Intravenous
Male
Predictive Value of Tests
Prospective Studies
Tissue Plasminogen Activator / therapeutic use*
Chemical
Reg. No./Substance:
0/Fibrinolytic Agents; EC 3.4.21.68/Tissue Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Recurrent trigeminal neuralgia: long term outcome of repeat gamma knife radiosurgery.
Next Document:  Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of ac...